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Microorganisms have provided mankind with a multitude
of useful compounds ranging from industrial enzymes to
anti-cancer compounds and antibiotics. With the aging
population, our need for treatment principles against
cancer, Alzheimer’s disease and metabolic disorders is
increasing. Also, the occurrence and spread of antibiotic
resistance in pathogenic microorganisms has become
one of our main challenges. For a number of years, it was
hoped that our advances in chemical synthesis would
provide the desired novelty in terms of scaffolds and
targets, however, while there has been success, it has
also been realized that the complexity of natural (micro-
bial) products far surpasses anything possible by chemi-
cal synthesis. Hence, drug discovery has returned to
nature, especially microorganisms, as a source of novel
chemistry. Recently, genome sequencing and mining has
demonstrated that bioactive compounds hitherto believed
to be produced by a eukaryotic organism (a marine
sponge) were indeed synthesized by one of the dominant
(uncultured) prokaryotes, ‘Entotheonella’ further underlin-
ing the vast bioactive underestimated potential in micro-
organisms (Wilson et al., 2014).
Classical bioassay guided fractionation has been used
for decades as the major bioprospecting path, however,
this is often a laborious process, and rediscovery of
known compounds is a major challenge despite develop-
ments in de-replication strategies. The rapidly developing
sequencing techniques are introducing sequencing of
microbial genomes in almost any microbial research envi-
ronment, and hence so-called genome mining has
become a useful tool in discovery of novel microbial prod-
ucts (Jensen et al., 2014). Despite the complexity of the
bioactive secondary metabolites produced by microor-
ganisms, several pathways are conserved at the modular
level. This has allowed the development of software,
such as ANTISMASH or NAPDOS, which can identify
characteristic structures of polyketide and non-ribosomal
peptide synthetases (Weber 2014). Such genome mining
processes have revealed that the bioactive potential in
numerous microorganisms is likely much higher than pre-
viously discovered by bioassay-guided fractionation. This
has been demonstrated for well-known producers of anti-
biotics, in Actinobacteria and fungi. However, it is also true
for several groups of Gram-negative prokaryotes (Still
et al., 2014) that hitherto have not been thought of as
useful producers of bioactive compounds. For instance in
Pseudoalteromonas luteoviolaceae, 3–4 bioactive com-
pounds have been isolated (violacein, indolmycin,
pentabromopseudilin), however, genome mining reveals
approximately 15 gene clusters likely encoding for
pathways likely producing bioactives (H. Machado,
unpublished).
It is believed that the reason for the ‘non-discovery’ of
these potential novel compounds is largely because the
genes are not expressed during normal laboratory culti-
vation; so-called silent gene clusters. Hence, the activa-
tion or use of such silent clusters is becoming a hot
research topic. How to unlock this potential? How to make
the silent clusters ‘speak up’? Several paths are being
pursued. One is based on synthetic biology with the
approach of cloning the clusters and expressing in
heterologous hosts. There are examples of success from
this approach (Ross et al., 2014), and more are likely to
come. However, there are also several challenges. The
gene clusters encoding putative bioactive compounds are
typically large (10–100 kb) and often consists of many
genes. Hence, the cloning and expression is significantly
more challenging than cloning of a single gene and
expressing its product. Also, the clusters/genes may fail to
express in a heterologous host due to lack of signals
naturally present in the native producer.
Another path involves the modification of gene expres-
sion in the natural producer organism in a general sense.
In fungi, inhibitors of histone deacetylation can induce
secondary metabolism by increasing promoter acces-
sibility due to changes in chromatin structure. Analo-
gously, expression of otherwise silent gene clusters in
Streptomyes coelicolor has been demonstrated using
histone deacetylation inhibitors as elicitors (Moore et al.,
2012). Japanese researchers have successfully used
genetic modification of the producer microorganism to
elicit bioactive compound production. Approaches include
‘ribosome engineering’ as well as overexpression of regu-
lator proteins (Ochi and Hosaka, 2013).
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A broad range of approaches all fall under the same
overall strategy, involving variation of growth conditions of
the potential producing organism with subsequent chemi-
cal analyses (LC-MS, MS/MS) and bioassays. A vast
amount of studies have demonstrated that the production
of secondary metabolites in microorganisms is dependent
on growth substrate and environment. Stress signals,
such as antibiotics (Seyedsayamdost, 2014), ppGpp,
nutrient depletion or physical stress can induce silent
clusters and production of bioactives. Also, several groups
are working on culture approaches where the conditions
are mimicking the natural chemical and/or biological
environment of the potential producing microorganisms
(Schroeckh et al., 2009; Lincke et al., 2010). This also
covers switching from test tubes and flasks to using biofilm
mode of growth, co-cultivation systems (König et al.,
2013) and natural co-occurring nutrients. Especially, the
production of novel compounds as a result of co-culturing
has been beautifully demonstrated by use of direct chemi-
cal probing (nanospray desorption electrospray ionization
and microbial matrix-assisted laser desorption ionization-
time of flight imaging mass spectrometry) (Traxler et al.,
2013). We demonstrated (Wietz et al., 2011) that culturing
marine bacteria on chitin, the dominant organic polymer
in marine systems, as opposed to glucose dramatically
altered the secondary metabolism, and the bacterium
focused its production on bioactive compounds. In a
simple agar screen for antibiotic activity, we recently found
that if the producer organisms were grown on chitin, the
number of isolates with antibacterial activity tripled (S.
Giubergia, unpublished).
Likely, the future will see a combination of several
approaches and technologies. Aligning manipulations
of culture conditions (natural substrates, associate
microbiota) with chemical (metabolomic molecular net-
working), genome and metagenome-based analyses is
indeed likely to enhance our bio-discovery hit rate and
provide novel understanding of the ecology and natural
interactions of microorganisms.
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